Zalifrelimab (Anti-CTLA-4 / CD152)
Zalifrelimab (Anti-CTLA-4 / CD152) is a recombinant human monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with immune checkpoint inhibitory and antineoplastic activities. MW: 144.48 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2860 |
| Sku # | A2860-1mg*5 |
| Pricing | 1mg*5, $1690.00 |